Bank of Nova Scotia’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Bank of Nova Scotia's MRK Position: Q1 2026 in Review
Bank of Nova Scotia reduced its Merck (MRK) stake by 26% in Q1 2026, selling an estimated $57.6M and leaving 1,457,238 shares worth $175M. The position accounts for 0.31% of the portfolio, ranked #55.
Bank of Nova Scotia first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $343M in Q4 2023. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Bank of Nova Scotia held 1,457,238 shares of Merck worth $175M as of Q1 2026.
- Bank of Nova Scotia sold 498,962 Merck shares in Q1 2026, an estimated $57.6M.
- Merck made up 0.31% of Bank of Nova Scotia's portfolio in Q1 2026, its #55 holding.
- Bank of Nova Scotia first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Bank of Nova Scotia's Merck position peaked at $343M in Q4 2023.
- 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.